Trans-cinnamaldehyde protects against phenylephrine-induced cardiomyocyte hypertrophy through the CaMKII/ERK pathway

BACKGROUND: Trans-cinnamaldehyde (TCA) is one of the main pharmaceutical ingredients of Cinnamomum cassia Presl, which has been shown to have therapeutic effects on a variety of cardiovascular diseases. This study was carried out to characterize and reveal the underlying mechanisms of the protective...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Dongdong, Tian, Jing, Wang, Sining, Shan, Xiaoli, Zhao, Pei, Chen, Huihua, Xu, Ming, Guo, Wei, Zhang, Chen, Lu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040265/
https://www.ncbi.nlm.nih.gov/pubmed/35468773
http://dx.doi.org/10.1186/s12906-022-03594-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040265/
https://www.ncbi.nlm.nih.gov/pubmed/35468773
http://dx.doi.org/10.1186/s12906-022-03594-1

Ejemplares similares